InDex Pharmaceuticals comments on trial

InDex Pharmaceuticals AB of Sweden said that data from a compassionate use programme of its experimental therapy for treating ulcerative colitis has been published in the journal, Inflammatory Bowel Diseases.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Sweden